Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-25

Clinical Trial Update: Perindopril Amlodipine for the Treatment of Hypertension [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluating the fixed-dose combination of perindopril and amlodipine for essential hypertension has completed, with results posted in August 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perindopril/amlodipine (perindopril/amlodipine)

Snippet

Sponsor: Symplmed Pharmaceuticals LLC | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2015-08-25